Compare DNLI & LXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNLI | LXP |
|---|---|---|
| Founded | 2013 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.9B |
| IPO Year | 2017 | N/A |
| Metric | DNLI | LXP |
|---|---|---|
| Price | $20.94 | $48.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $30.80 | ★ $52.83 |
| AVG Volume (30 Days) | ★ 1.6M | 575.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.77% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.71 |
| Revenue Next Year | $3,886.00 | $8.03 |
| P/E Ratio | ★ N/A | $26.35 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.57 | $6.85 |
| 52 Week High | $23.77 | $52.52 |
| Indicator | DNLI | LXP |
|---|---|---|
| Relative Strength Index (RSI) | 57.99 | 46.75 |
| Support Level | $13.29 | $47.35 |
| Resistance Level | $23.77 | $51.69 |
| Average True Range (ATR) | 1.20 | 1.51 |
| MACD | -0.05 | -0.27 |
| Stochastic Oscillator | 69.29 | 36.47 |
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.